Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06545032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Sep 2025 to Sep 5, 2026 Show 6 more changesShow less
    • Study completion date changed from estimate of Oct 2025 to Sep 10, 2026
    • Trial status changed: Unknown → Completed
    • Trial arms changed: 0 → 1
    • Start date changed from estimate of Sep 2024 to Sep 15, 2024
    • Eligibility criteria expanded, about 11 words
    • Publications: details revised at 4 of 4 entries
  2. Minor Changed Registry marked status Unknown; last known: Not Yet Recruiting
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
498 trials monitored
See 2 trials at risk
The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.
Trial Details
NCT Number NCT06545032
Lead Sponsor Sohag University
Conditions
(from sponsor)
Degenerative Spine Diseases
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov